Next |
home / stock / gkos / gkos message board
Subject | By | Source | When |
---|---|---|---|
This could run hard with volume | masterofdisaster | investorshub | 07/30/2021 2:23:47 PM |
I put a bid in on the Aug. | masterofdisaster | investorshub | 07/15/2021 11:47:00 AM |
Priced a little high for me. I was | KOmani | investorshub | 07/15/2021 11:45:10 AM |
I was thinking about buying some $60 call options | masterofdisaster | investorshub | 07/14/2021 9:07:03 PM |
Anyone else trading this hoping it can test $60? | KOmani | investorshub | 07/14/2021 2:51:02 PM |
Heard we got news today | PennyStock Alert | investorshub | 09/17/2019 3:36:58 PM |
Glaukos Announces FDA Approval for the iStent inject | Stock Logics | investorshub | 06/25/2018 11:14:18 AM |
GKOS buy 30.3 | stocktrademan | investorshub | 03/06/2018 7:40:55 PM |
I am up over 23k here! | ProTrader4000 | investorshub | 05/05/2016 1:33:33 AM |
$GKOS WEEKLY | TREND1 | investorshub | 12/02/2015 5:42:20 PM |
$GKOS 10 MINUTES | TREND1 | investorshub | 11/12/2015 11:21:15 PM |
$GKOS DAY | TREND1 | investorshub | 11/11/2015 6:08:26 PM |
The FA looks great, but the stock is | TREND1 | investorshub | 11/10/2015 10:29:31 PM |
Today : Tuesday 10 November 2015 | TREND1 | investorshub | 11/10/2015 10:27:42 PM |
$GKOS D | TREND1 | investorshub | 11/10/2015 9:51:49 PM |
GKOD D 4 MONTHS | TREND1 | investorshub | 08/15/2015 8:57:23 PM |
float 13.85 m | TREND1 | investorshub | 08/13/2015 8:52:17 PM |
WEB SITE | TREND1 | investorshub | 08/13/2015 7:27:16 PM |
Second Quarter 2015 Financial Results | TREND1 | investorshub | 08/13/2015 7:24:44 PM |
$GKOS 30 D W M PF | TREND1 | investorshub | 08/13/2015 7:20:15 PM |
News, Short Squeeze, Breakout and More Instantly...
Shares of Glaukos Corporation (NYSE: GKOS) traded at a new 52-week high today and are currently trading at $102.98. So far today, approximately 56,347 shares have been exchanged, as compared to an average 30-day volume of 529.81k shares. Glaukos Corporation, an ophthalmic medical technology a...
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has published its 2023 Sustainability Report. The report highlights the company...
2024-04-11 22:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...